Skip to main content
. 2017 Dec 7;103(3):438–446. doi: 10.3324/haematol.2017.181297

Figure 6.

Figure 6.

Survival according to non-driver mutation status. (A) Overall survival and (B) leukemia-free survival according to the presence of at least one mutation. (C) Overall survival and (B) leukemia-free survival according to the presence of one of the high molecular risk mutations. High molecular risk is defined by the presence of one of the five following mutations: ASXL1, SRSF2, EZH2 or IDH1/2.